Hai Phong Petrolimex Transportation and Services JSC (HNX:PTS)

Theseus Pharmaceuticals Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Revenue	367,981	381,961	393,817	444,764	350,334	346,074
Revenue Growth (YoY)	-4.66%	-3.01%	-11.46%	26.95%	1.23%	12.13%
Cost of Revenue	317,225	338,990	356,376	393,415	300,827	301,478
Gross Profit	50,756	42,971	37,441	51,349	49,507	44,595
Selling, General & Admin	31,793	30,561	28,362	30,745	27,949	22,956
Operating Expenses	31,793	30,561	28,362	30,745	27,949	22,956
Operating Income	18,963	12,410	9,080	20,604	21,557	21,640
Interest Expense	-8,166	-8,166	-12,385	-8,286	-9,119	-15,018
Interest & Investment Income	17.46	17.46	14.93	39.12	20.3	46.33
Other Non Operating Income (Expenses)	1,994	27.03	135.84	-734.2	2,119	576.57
EBT Excluding Unusual Items	12,808	4,288	-3,155	11,624	14,577	7,244
Gain (Loss) on Sale of Assets	180.47	1,261	4,188	-	-	-
Other Unusual Items	-597.98	-548.93	-	-	-	-
Pretax Income	12,391	5,000	1,034	11,624	14,577	7,244
Income Tax Expense	2,816	1,179	655.13	2,358	3,149	1,452
Net Income	9,574	3,821	378.66	9,266	11,428	5,792
Preferred Dividends & Other Adjustments	-	-	300	-	-	-
Net Income to Common	9,574	3,821	78.66	9,266	11,428	5,792
Net Income Growth	13648.42%	909.15%	-95.91%	-18.92%	97.30%	13.28%
Shares Outstanding (Basic)	6	6	6	6	6	6
Shares Outstanding (Diluted)	6	6	6	6	6	6
Shares Change (YoY)	-0.33%	-	-0.01%	-6.98%	7.48%	-0.01%
EPS (Basic)	1722.33	686.30	14.13	1664.00	1909.00	1040.00
EPS (Diluted)	1722.33	686.30	14.13	1664.00	1909.00	1040.00
EPS Growth	-	4757.70%	-99.15%	-12.83%	83.56%	13.29%
Free Cash Flow	13,764	10,938	6,939	21,712	31,470	60,869
Free Cash Flow Per Share	2476.04	1964.41	1246.17	3899.06	5257.05	10929.01
Dividend Per Share	500.000	500.000	-	800.000	-	-
Gross Margin	13.79%	11.25%	9.51%	11.54%	14.13%	12.89%
Operating Margin	5.15%	3.25%	2.31%	4.63%	6.15%	6.25%
Profit Margin	2.60%	1.00%	0.02%	2.08%	3.26%	1.67%
Free Cash Flow Margin	3.74%	2.86%	1.76%	4.88%	8.98%	17.59%
EBITDA	44,163	37,782	33,218	44,228	47,835	48,186
EBITDA Margin	12.00%	9.89%	8.43%	9.94%	13.65%	13.92%
D&A For EBITDA	25,200	25,372	24,138	23,624	26,278	26,546
EBIT	18,963	12,410	9,080	20,604	21,557	21,640
EBIT Margin	5.15%	3.25%	2.31%	4.63%	6.15%	6.25%
Effective Tax Rate	22.73%	23.58%	63.37%	20.28%	21.61%	20.04%
Revenue as Reported	367,981	381,961	393,817	444,764	350,334	346,074

Source: S&P Global Market Intelligence. Standard template. Financial Sources.